In our study, we identified four distinct biomarker statuses based on comprehensive data and repeatedly collected blood samples of a large European children cohort including: “normal”, “low leptin/IGF-1/HbA1c”, “inflammation” and “dyslipidemia/high leptin”. The gene discussed is LEP; the disease is metabolic syndrome.